Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Galena Biopharma GALE

Healthcare Biotechnology
"Galena Biopharma is a biopharmaceutical company. Its main activity is the development and commercialization of hematology and oncology therapies. Its pipeline includes products targeting hematology diseases, breast cancer, gastric cancer, and gynecological cancer. The company’s cancer immunotherapy consists of two areas: prevention of cancer reoccurrence and primary prevention of invasive... see more

Recent & Breaking News (NDAQ:GALE)

Galena Biopharma Announces Notice of Allowance of U.S. Patent Application for NeuVax(TM) (nelipepimut-S) Combination

GlobeNewswire October 8, 2014

Galena Biopharma Announces Release of Special Committee Report and Hosting of a Conference Call to Provide a Corporate Update

GlobeNewswire September 25, 2014

Galena Biopharma Doses First Patient in GALE-401 (Anagrelide Controlled Release) Phase 2 Clinical Trial

GlobeNewswire September 9, 2014

Galena Biopharma Inc. (GALE) Jumps 7.17% on September 5

Equities.com September 5, 2014

Galena Biopharma to Present at the Rodman & Renshaw 16th Annual Global Investment Conference

GlobeNewswire September 3, 2014

Leading Health Care Stock for Small-Cap Stars is Galectin Therapeutics Inc. (GALT) for August 27

Equities.com August 27, 2014

Leading Small-Cap Stars Health Care Stock for August 27 Morning Session is Galena Biopharma Inc. (GALE)

Equities.com August 27, 2014

Rex American Resources (REX) Leads Small-Cap Stars in Early Trading for August 27

Equities.com August 27, 2014

Leading Health Care Stock for Small-Cap Stars is Arrowhead Research Corp (ARWR) for August 26

Equities.com August 26, 2014

Galena Biopharma Inc. (GALE) Drops 5.17% on August 21

Equities.com August 21, 2014

Galena Biopharma Appoints Mark W. Schwartz, Ph.D., as President and Chief Executive Officer

GlobeNewswire August 21, 2014

Galena Biopharma Reports Second Quarter 2014 Results

GlobeNewswire August 11, 2014

Rodman & Renshaw 2014 Annual Global Investment Conference to be held in New York from September 8 to 10, 2014

Business Wire August 11, 2014

Leading Health Care Stock for Small-Cap Stars is Horizon Pharma Inc. (HZNP) for August 7

Equities.com August 7, 2014

Leading Small-Cap Stars Health Care Stock for August 7 Morning Session is Horizon Pharma Inc. (HZNP)

Equities.com August 7, 2014

Galena Biopharma to Report Second Quarter 2014 Financial Results on Monday, August 11, 2014

GlobeNewswire July 29, 2014

Aradigm Corp. (ARDM) Leads Small-Cap Stars Health Care Sector for July 22

Equities.com July 22, 2014

MonoSol Rx Enters Into Exclusive Licensing Agreement With Galena Biopharma for Zuplenz(R) Oral Soluble Film

GlobeNewswire July 22, 2014

Galena Biopharma Enters Into Definitive Agreement to License U.S. Rights for Zuplenz(R) (ondansetron) Oral Soluble Film

GlobeNewswire July 22, 2014

Galena Biopharma Receives Notice of Allowance of Broad U.S. Patent for NeuVax(TM) (nelipepimut-S)

GlobeNewswire July 1, 2014